News

Japan Approves Remdesivir For Coronavirus Treatment

Japan Approves Remdesivir For Coronavirus Treatment

 

 

Japan on Thursday authorised the antiviral drug remdesivir to treat coronavirus patients, the government said, with an eye to approving another medication Avigan this month.

This makes Japan the second country to approve the drug after US regulators authorised it on Friday for emergency use against severe cases of COVID-19.

“Remdesivir was approved under exceptional measures,” a health, labour and welfare ministry official said.

“It was our country’s first such approval for the treatment of coronavirus patients,” the official told AFP.

Prime Minister Shinzo Abe said last week the government was getting ready to give a speedy green light to the experimental drug developed by US firm Gilead Sciences.

The US go-ahead came after a major clinical trial showed remdesivir — originally developed to treat Ebola — shortened the time to recovery in some patients by a third.

The difference in mortality rate was not statistically significant.

Remdesivir, which is administered by injection, was already available to some patients who enrolled in clinical trials around the world.

As for Avigan, developed by Japanese firm Fujifilm Toyama Chemical, top government spokesman Yoshihide Suga said the government “aims to approve it this month” if a clinical trial involving 100 patients proves effective.

The drug, whose generic name is favipiravir, was approved for use in Japan in 2014 but only in flu outbreaks that are not being effectively addressed by existing medications.

It is not available on the market and can only be manufactured and distributed at the request of the Japanese government.

Favipiravir, which can be taken orally as a pill, works by blocking the ability of a virus to replicate inside a cell.

Remdesivir incorporates itself into the virus’s genome, short-circuiting its replication process.

Avigan has been shown in animal studies to affect fetal development, meaning it is not given to pregnant women.

 

AFP

 

Angela Davies

Recent Posts

SDNON Unveils Ambitious Plans For 2025, Celebrates Outgoing Executives

The newly elected SDNON excos have unveiled their ambitious plans for 2025 and celebrated the outgoing executives.…

4 hours ago

Primate Ayodele Releases 2025 Prophecies For All Sectors

The leader of the INRI Evangelical Spiritual Church, Primate Elijah Ayodele, has released his 2025…

14 hours ago

Timeless Tunes: How Throwback Songs Bond Africans In 2024

Music has always been central to African culture, reflecting societal changes while connecting generations. In…

2 days ago

Sinach To Feature In Global Christian Event, Gather25

Sinach is set to feature in the global Christian event, Gather25.   Glamtush reports that Gather25,…

2 days ago

Yahaya Bello Released After Meeting Bail Conditions

Yahaya Bello has been released after meeting his bail conditions.   Glamtush reports that former…

2 days ago

Makinde Cancels Birthday Celebration To Honour Ibadan Stampede Victims

Makinde has cancelled his birthday celebration to honour the Ibadan stampede victims.   Glamtush reports that Governor…

2 days ago